FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to neurology, and concerns treating a movement abnormality. It is made by administering a therapeutically effective amount of a PDE7 inhibitory agent representing
or
.
EFFECT: method provides motor function recovery in some neurological diseases, including Parkinson's disease, by administering the above mentioned compounds in minimum doses due to their selective inhibition with PDE7.
8 cl, 23 dwg, 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS | 2013 |
|
RU2665134C2 |
| TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS | 2011 |
|
RU2661410C2 |
| USING PDE7 INHIBITORS FOR TREATING MOVEMENT DISORDERS | 2008 |
|
RU2449790C2 |
| PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
| METHOD FOR PRODUCING [(3-HYDROXYPYRIDINE-2-CARBONYL)AMINO]ALKANE ACIDS, ESTERS AND AMIDES | 2012 |
|
RU2764667C2 |
| APPLICATION OF 2-(2-NITRO-4-TRIFLUORMETHYLBENZOYL)-1,3-CYCLOHEXANDIONE IN TREATMENT OF PARKINSON'S DISEASE | 2006 |
|
RU2420272C2 |
| SUBSTITUTED DIHYDROTHIENOPYRIMIDINES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | 2018 |
|
RU2817698C2 |
| DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD | 2000 |
|
RU2293728C2 |
| COMBINATIONS CONTAINING mGluR MODULATORS FOR TREATING PARKINSON'S DISEASE | 2009 |
|
RU2496494C2 |
| HYDROXYBENZOATE SALTS OF METANICOTINIC COMPOUNDS | 2005 |
|
RU2409566C2 |
